» Authors » John Boletis

John Boletis

Explore the profile of John Boletis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 56
Citations 1105
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Carter S, Teng C, Gutman T, Logeman C, Cattran D, Lightstone L, et al.
Kidney Int Rep . 2022 Jan; 7(1):56-67. PMID: 35005314
Introduction: Patients with glomerular disease experience symptoms that impair their physical and mental health while managing their treatments, diet, appointments and monitoring general and specific indicators of health and their...
12.
Carter S, Lightstone L, Cattran D, Tong A, Bagga A, Barbour S, et al.
Clin J Am Soc Nephrol . 2021 Dec; 17(1):53-64. PMID: 34969698
Background And Objectives: Outcomes reported in trials in adults with glomerular disease are often selected with minimal patient input, are heterogeneous, and may not be relevant for clinical decision making....
13.
Agarwal R, Anker S, Filippatos G, Pitt B, Rossing P, Ruilope L, et al.
Nephrol Dial Transplant . 2021 Dec; 37(7):1261-1269. PMID: 34850173
Background: The nonsteroidal mineralocorticoid receptor antagonist finerenone and the sodium-glucose cotransporter-2 inhibitor (SGLT-2i) canagliflozin reduce cardiorenal risk in albuminuric patients with chronic kidney disease (CKD) and type 2 diabetes (T2D)....
14.
Tsiakas S, Marinaki S, Lionaki S, Boletis J
J Clin Med . 2021 Nov; 10(21). PMID: 34768675
Therapeutic plasma exchange (TPE) is an adjunctive intervention to immunosuppression for the treatment of severe renal involvement or lung hemorrhage in patients with ANCA-associated vasculitis (AAV). Patients with AAV have...
15.
Chavatza K, Kostopoulou M, Nikolopoulos D, Gioti O, Togia K, Andreoli L, et al.
Ann Rheum Dis . 2021 Jun; 80(9):1175-1182. PMID: 34162597
Background: Quality of care is receiving increased attention in systemic lupus erythematosus (SLE). We developed quality indicators (QIs) for SLE based on the 2019 update of European League Against Rheumatism...
16.
Halimi J, Ortiz A, Sarafidis P, Mallamaci F, Wuerzner G, Pisano A, et al.
J Hypertens . 2021 May; 39(8):1513-1521. PMID: 34054055
Hypertension is common in kidney transplantation recipients and may be difficult to treat. Factors present before kidney transplantation, related to the transplantation procedure itself and factors developing after transplantation may...
17.
Marinaki S, Tsiakas S, Liapis G, Skalioti C, Kapsia E, Lionaki S, et al.
Medicine (Baltimore) . 2021 May; 100(20):e26022. PMID: 34011106
Fibrillary glomerulonephritis (FGN) is a diverse glomerular disease with poor renal prognosis. The optimal therapeutic approach remains undetermined, as treatment outcomes vary across different studies.We retrospectively reviewed the medical data...
18.
Carter S, Logeman C, Howell M, Cattran D, Lightstone L, Bagga A, et al.
Kidney Int . 2021 May; 100(4):881-893. PMID: 33964313
Outcomes relevant to treatment decision-making are inconsistently reported in trials involving glomerular disease. Here, we sought to establish a consensus-derived set of critically important outcomes designed to be reported in...
19.
Tsikala-Vafea M, Basoulis D, Pavlopoulou I, Darema M, Deliolanis J, Daikos G, et al.
Transpl Infect Dis . 2020 Aug; 22(6):e13442. PMID: 32780553
Background: Kidney transplant recipients (KTRs) are at increased risk of infections. Methods: The aims of this study were to describe the incidence of bloodstream infections (BSIs) by gram-negative bacteria in...
20.
Kostopoulou M, Fanouriakis A, Cheema K, Boletis J, Bertsias G, Jayne D, et al.
RMD Open . 2020 Jul; 6(2). PMID: 32699043
Objectives: To analyse the current evidence for the management of lupus nephritis (LN) informing the 2019 update of the EULAR/European Renal Association-European Dialysis and Transplant Association recommendations. Methods: According to...